These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 13548546)

  • 1. [The effect of cortisone on the experimental infection of guinea pigs with isoniazid-resistant Mycobacterium tuberculosis].
    GIALDRONI-GRASSI G; GRASSI C; LEIDI F; PERNA G
    G Ital Della Tuberc; 1958; 12(2):65-70. PubMed ID: 13548546
    [No Abstract]   [Full Text] [Related]  

  • 2. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of pathological processes after intranasal and subcutaneous infection of guinea pigs. II. Isonicotinic acid hydrazide (INH) resistant strains of Mycobacterium tuberculosis].
    PRZEWORSKA-KANIEWICZ D
    Gruzlica (1926); 1960 Dec; 28():949-54. PubMed ID: 13738336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the somatotropic hormone, cortisone and desoxycorticosterone combined with isoniazid on experimental tuberculosis in guinea pigs].
    BESTA B; LUCCHESI M; VALENTI S; MARINO T
    Ann Ist Carlo Forlanini; 1954; 14(2):171-7. PubMed ID: 13207936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of some strains of Mycobacterium tuberculosis that are resistant to isoniazid and highly pathogenic for guinea pigs. II. Discussion of the findings].
    LIBERMANN C
    Ann Inst Pasteur (Paris); 1958 Oct; 95(4):432-48. PubMed ID: 13583666
    [No Abstract]   [Full Text] [Related]  

  • 6. THE FOCUS OF INOCULATION IN GUINEA PIGS DURING TREATMENT WITH MORFOZINAMIDE. (INFECTION WITH STRAINS SENSITIVE AND RESISTANT TO CHEMOTHERAPY AND ANTIBIOTICS.
    CATENA E; ALIPERTA A; ROCCO V
    Arch Tisiol Mal Appar Respir; 1963 Apr; 18():366-77. PubMed ID: 14055802
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study on isoniazid-resistant Mycobacterium tuberculosis isolates by multiple-polymerase chain reaction-single strand conformation polymorphism].
    Cheng XD; Yu WB; Bie LF; Su MQ; Zhang R; Hao XK
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):23-6. PubMed ID: 14989821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
    Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
    Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment of the guinea pig model of synovial tuberculosis of knee joint by mycobacterium tuberculosis H37Rv infection].
    Li WL; Song YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):804-6, 809. PubMed ID: 17037758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histological studies of the early parenchymal reactions of guinea pigs inoculated with isoniazid-resistant Mycobacterium tuberculosis in crudely and finely dispersed suspension].
    PERELLI A; STORNIELLO G
    Ann Ist Carlo Forlanini; 1957; 17(3):259-72. PubMed ID: 13509451
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of gene chip in detecting Mycobacterium tuberculosis resistant to rifampin and isoniazid].
    Cui ZL; Jing FX; Hu ZY; Wu ZR; Zhao JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):439-41. PubMed ID: 15312553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antituberculosis activity of isoniazid in combination with sulfisoxazole (gantrisin). II. The effect of isoniazid in combination with sulfisoxazole on the experimental tuberculosis in guinea pigs and mice.
    NAITO M; MAEKAWA N; KUBO T; HAMADA K; TSUJINO H
    Acta Tuberc Jpn; 1960 Dec; 10():57-66. PubMed ID: 13727548
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of the proteomes of isoniazid-resistant Mycobacterium tuberculosis strains and isoniazid-susceptible strains].
    Jiang X; Gao F; Zhang WH; Hu ZY; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):427-31. PubMed ID: 17673015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands.
    van Doorn HR; de Haas PE; Kremer K; Vandenbroucke-Grauls CM; Borgdorff MW; van Soolingen D
    Clin Microbiol Infect; 2006 Aug; 12(8):769-75. PubMed ID: 16842572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple mutations in katG and inhA identified in Thai isoniazid-resistant Mycobacterium tuberculosis isolates.
    Khadka DK; Eampokalap B; Panitchakorn J; Ramasoota P; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):376-82. PubMed ID: 17539290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wide range of the use of natural lipases and esterases to inhibit Mycobacterium tuberculosis].
    Annenkov GA; Klepikov NN; Martynova LP; Puzanov VA
    Probl Tuberk Bolezn Legk; 2004; (6):52-6. PubMed ID: 15315135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
    Tudó G; González J; Obama R; Rodríguez JM; Franco JR; Espasa M; Simarro PR; Escaramís G; Ascaso C; García A; Jiménez de Anta MT
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):15-22. PubMed ID: 14974741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East.
    Ahmad S; Mokaddas E
    Int J Antimicrob Agents; 2004 May; 23(5):473-9. PubMed ID: 15120726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.